Clarfeld Financial Advisors’s AstraZeneca AZN Stock Holding History

Clarfeld Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$7K	Buy	+98	New	+$7.65K	0.01%	270

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Clarfeld Financial Advisors's AZN Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in AstraZeneca (AZN) in Q4 2018: 98 shares worth $7K. The stake represents 0.01% of the portfolio and ranks #270 among its holdings.

557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

Clarfeld Financial Advisors held 98 shares of AstraZeneca worth $7K as of Q4 2018.
AstraZeneca was a new Clarfeld Financial Advisors position in Q4 2018.
AstraZeneca made up 0.01% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #270 holding.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.